Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  02/27/2004
 
Trade Name:  Myfortic Delayed-Release Tablets
 
Generic Name or Proper Name (*):  mycophenolic acid
 
Indications Studied:  Prevention of organ rejection in patients receiving allogeneic renal transplants in children 5-16 years of age with stable renal transplants
 
Label Changes Summary:  * Approval based on extrapolation of safety and effectiveness in adult patients * One PK study with information down to 5 years of age * Waived studies in birth to 10 years because there are too few children to study. * New active ingredient
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  Novartis
 
NNPS:  FALSE
 
Therapeutic Category:  Immunosuppressant
 
-
-